# Potassium Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/potassium-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Potassium Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-05-27
Reviewed by: Migaku Evidence Review
# Potassium Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Potassium Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The effect of nutrition education interventions on dialysis patients’ outcomes: a systematic review and meta-analysis | systematic review | 1 | 2026-04-22 | 10.1080/07853890.2026.2660389 |
| Effects of Aliskiren Monotherapy on Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Blood Pressure and Urinary Protein Excretion Outcomes | systematic review | 1 | 2026-03-21 | 10.1111/jch.70237 |

## What The Sources Report

- Various factors may contribute to reduced treatment adherence, notably insufficient knowledge, which is a key factor that, alongside considerations such as attitude and satisfaction, affects adherence. [Sarmadi Sogand (2026); evidence level 1]
- Failure to comply with dietary guidelines and fluid management in these patients may cause elevated blood pressure, fluid retention, edema, hyperkalemia, hyperphosphatemia, and a heightened risk of cardiovascular disease, potentially leading to recurrent hospitalizations and mortality. [Sarmadi Sogand (2026); evidence level 1]
- Data from large potential cohorts in the general population and in treated hypertensive patients suggest that hypertension is an independent risk factor for adverse renal outcomes, with a close relationship between the level of blood pressure and the incidence and progression of CKD. [Bhuiya N M Mahmudul Alam (2026); evidence level 1]
- Conversely, CKD is an independent risk factor for the development of hypertension and cardiovascular disease. [Bhuiya N M Mahmudul Alam (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For potassium blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Sarmadi Sogand (2026). The effect of nutrition education interventions on dialysis patients’ outcomes: a systematic review and meta-analysis. DOI: 10.1080/07853890.2026.2660389. PMCID: PMC13104004. PMID: 42015790. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13104004/
- Bhuiya N M Mahmudul Alam (2026). Effects of Aliskiren Monotherapy on Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Blood Pressure and Urinary Protein Excretion Outcomes. DOI: 10.1111/jch.70237. PMCID: PMC13097542. PMID: 41863844. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This is an open access.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13097542/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.